Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.290
+0.010 (0.78%)
At close: Apr 23, 2025, 4:00 PM
1.310
+0.020 (1.55%)
Pre-market: Apr 24, 2025, 8:01 AM EDT
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 3.88, with a low estimate of 2.00 and a high estimate of 7.50. The average target predicts an increase of 200.78% from the current stock price of 1.29.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lucid Diagnostics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7 → $7.5 | Strong Buy | Maintains | $7 → $7.5 | +481.40% | Apr 21, 2025 |
Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +132.56% | Apr 11, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $2 | Buy | Reiterates | $2 | +55.04% | Mar 26, 2025 |
Needham | Needham | Strong Buy Maintains $2.5 → $3 | Strong Buy | Maintains | $2.5 → $3 | +132.56% | Mar 24, 2025 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.25 → $7 | Strong Buy | Maintains | $7.25 → $7 | +442.64% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
9.64M
from 4.35M
Increased by 121.84%
Revenue Next Year
30.94M
from 9.64M
Increased by 220.91%
EPS This Year
-0.58
from -1.05
EPS Next Year
-0.35
from -0.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.6M | 50.9M | 61.6M | ||
Avg | 9.6M | 30.9M | 43.4M | ||
Low | 6.2M | 11.9M | 25.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 189.9% | 427.7% | 99.2% | ||
Avg | 121.8% | 220.9% | 40.1% | ||
Low | 42.1% | 23.1% | -16.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.49 | -0.26 | -0.09 | ||
Avg | -0.58 | -0.35 | -0.09 | ||
Low | -0.77 | -0.50 | -0.08 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.